James Gilbart has a first degree in microbiology and started out working in a hospital pathology lab in London then moved Porton Down and gained a PhD in microbiological research. He then spent four years as a post-doctoral fellow in arthritis research at a medical school in South Carolina. He then returned to the UK to work in the pharmaceutical industry on anti-infective research at the bench and later moved into regulatory writing. James has been a medical writer with various different regulatory and medical communications agencies since 1999 during which time he has written and edited various types of documents for the pharmaceutical industry. He has prepared regulatory documents including clinical study reports, safety update reports and study tabulations and clinical trial summaries for pharmaceutical clients. He has also written reviews, meeting reports, original articles, abstracts, posters, slide sets, and congress materials. These documents have covered a wide range of therapeutic areas including neurology, infectious disease, vaccines, oncology, cardiology, psychiatry, ophthalmology, musculoskeletal, urology, endocrinology and nephrology. After the med coms agencies James moved to a medical/ pharmaceutical publishing company where he has written numerous current reviews and congress reports on a large number of different drugs various different therapeutic areas and has initiated new projects with pharmaceutical clients and has managed other writers.